These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 7125844

  • 1. Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia.
    Castellani S, Ziegler MG, van Kammen DP, Alexander PE, Siris SG, Lake CR.
    Arch Gen Psychiatry; 1982 Oct; 39(10):1145-9. PubMed ID: 7125844
    [Abstract] [Full Text] [Related]

  • 2. Interactions of amphetamine, pimozide, and lithium on plasma norepineophrine and dopamine-beta-hydroxylase in schizophrenic patients.
    Rosenblatt JE, Lake CR, van Kammen DP, Ziegler MG, Bunney WE.
    Psychiatry Res; 1979 Jul; 1(1):45-52. PubMed ID: 298337
    [Abstract] [Full Text] [Related]

  • 3. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
    Baron M, Gruen R, Levitt M, Kane J.
    Neuropsychobiology; 1982 Jul; 8(6):312-4. PubMed ID: 6131392
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive effect of E-643, a new alpha-adrenergic blocking agent.
    Kawasaki T, Uezono K, Abe I, Nakamuta S, Ueno M, Kawazoe N, Omae T.
    Eur J Clin Pharmacol; 1981 Jul; 20(6):399-405. PubMed ID: 6116609
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism.
    Lake CR, Ziegler MG, Murphy DL.
    Arch Gen Psychiatry; 1977 May; 34(5):553-6. PubMed ID: 558741
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma norepinephrine concentration and plasma dopamine-beta-hydroxylase activity in patients with congestive heart failure.
    Minami M, Yasuda H, Yamazaki N, Kojima S, Nishijima H, Matsumura N, Togashi H, Koike Y, Saito H.
    Circulation; 1983 Jun; 67(6):1324-9. PubMed ID: 6851028
    [Abstract] [Full Text] [Related]

  • 14. Effect of acute volume alterations on norepinephrine and dopamine-beta-hydroxylase in normotensive and hypertensive subjects.
    Lake CR, Ziegler MG.
    Circulation; 1978 Apr; 57(4):774-8. PubMed ID: 630687
    [Abstract] [Full Text] [Related]

  • 15. Serum dopamine-beta-hydroxylase in schizophrenic patients.
    Fujita K, Ito T, Maruta K, Teradaira R, Beppu H, Nakagami Y, Kato Y, Nagatsu T, Kato T.
    J Neurochem; 1978 Jun; 30(6):1569-72. PubMed ID: 670998
    [No Abstract] [Full Text] [Related]

  • 16. Effects of desmethylimipramine on plasma norepinephrine, pulse, and blood pressure.
    Ross RJ, Zavadil AP, Calil HM, Linnoila M, Kitanaka I, Blombery P, Kopin IJ, Potter WZ.
    Clin Pharmacol Ther; 1983 Apr; 33(4):429-37. PubMed ID: 6831821
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.